SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -34.59%121M | 36.26%124M | 13.96%498M | 69.05%142M | 43.41%185M | -4.21%91M | -37.98%80M | 40.51%437M | -9.68%84M | 50.00%129M |
Net income from continuing operations | -455.56%-32M | 57.14%-3M | -70.49%54M | 11.76%38M | -84.75%9M | -112.50%-7M | -58.82%14M | 134.62%183M | -5.56%34M | 156.52%59M |
Operating gains losses | -66.67%-5M | 166.67%2M | 0.00%2M | -72.00%7M | 88.46%-3M | -175.00%-3M | 200.00%1M | --2M | --25M | -2,500.00%-26M |
Depreciation and amortization | 1.25%81M | -2.47%79M | 25.58%324M | 23.53%84M | 31.15%80M | 26.56%81M | 21.54%79M | 0.39%258M | 3.03%68M | -3.17%61M |
Deferred tax | -300.00%-6M | 140.00%4M | -92.54%5M | 566.67%14M | -88.46%3M | -147.62%-10M | -108.70%-2M | 4.69%67M | -114.29%-3M | 73.33%26M |
Other non cash items | -2.78%35M | 0.00%36M | 545.45%142M | 428.57%37M | 1,700.00%36M | 300.00%36M | 725.00%33M | 2,300.00%22M | 200.00%7M | 166.67%2M |
Change In working capital | -21.21%52M | 104.76%43M | 265.38%43M | 185.71%6M | 288.24%66M | 153.85%21M | -1,766.67%-50M | 62.32%-26M | 82.50%-7M | 254.55%17M |
-Change in receivables | ---- | 10.00%11M | 111.54%3M | ---- | ---- | 166.67%10M | 69.23%-4M | 79.03%-26M | ---- | ---- |
-Change in prepaid assets | ---- | 400.00%5M | --0 | ---- | ---- | -90.00%1M | -31.25%-21M | 146.15%6M | ---- | ---- |
-Change in payables and accrued expense | ---- | 440.00%27M | -66.67%-45M | ---- | ---- | 112.50%5M | -311.76%-36M | -148.21%-27M | ---- | ---- |
-Change in other current assets | ---- | -200.00%-1M | -66.67%2M | ---- | ---- | -80.00%1M | ---- | 500.00%6M | ---- | ---- |
-Change in other current liabilities | ---- | --2M | -200.00%-3M | ---- | ---- | --0 | 100.00%2M | 93.33%-1M | ---- | ---- |
-Change in other working capital | -21.21%52M | -125.00%-1M | 437.50%86M | 40.00%49M | 288.24%66M | 300.00%4M | -30.77%9M | -38.46%16M | 288.89%35M | --17M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -34.59%121M | 36.26%124M | 13.96%498M | 69.05%142M | 43.41%185M | -4.21%91M | -37.98%80M | 40.51%437M | -9.68%84M | 50.00%129M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -19.05%-25M | -12.00%-28M | -690.76%-941M | -3.33%-31M | -10.53%-21M | 48.98%-25M | -4,014.29%-864M | -8.18%-119M | 6.25%-30M | 52.50%-19M |
Net PPE purchase and sale | -25.00%-25M | -20.83%-29M | 15.24%-89M | -6.90%-31M | 23.08%-20M | 17.24%-24M | 33.33%-14M | -6.06%-105M | 9.38%-29M | 10.34%-26M |
Net business purchase and sale | --0 | --0 | -85,100.00%-852M | --0 | ---1M | ---1M | ---850M | 90.91%-1M | ---1M | --0 |
Net other investing changes | ---- | --1M | ---- | ---- | ---- | ---- | ---- | ---13M | --0 | --7M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -19.05%-25M | -12.00%-28M | -690.76%-941M | -3.33%-31M | -10.53%-21M | 48.98%-25M | -4,014.29%-864M | -8.18%-119M | 6.25%-30M | 52.50%-19M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 41.38%-102M | -49.23%-97M | 247.67%443M | -51.28%-118M | -109.64%-174M | 17.72%-65M | 1,433.33%800M | -27.66%-300M | -4.00%-78M | -144.12%-83M |
Net issuance payments of debt | 46.94%-78M | -92.11%-73M | 302.21%548M | -45.31%-93M | -88.46%-147M | 47.95%-38M | 1,575.00%826M | 60.95%-271M | -42.22%-64M | -160.00%-78M |
Net common stock issuance | --0 | 0.00%1M | 33.33%4M | 0.00%1M | --1M | 0.00%1M | 0.00%1M | -99.43%3M | 0.00%1M | --0 |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Net other financing activities | 0.00%-1M | 0.00%-1M | 55.56%-4M | 87.50%-1M | ---1M | 0.00%-1M | ---1M | 76.92%-9M | -300.00%-8M | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 41.38%-102M | -49.23%-97M | 247.67%443M | -51.28%-118M | -109.64%-174M | 17.72%-65M | 1,433.33%800M | -27.66%-300M | -4.00%-78M | -144.12%-83M |
Net cash flow | ||||||||||
Beginning cash position | 6.29%152M | 8.45%154M | 8.70%125M | -7.69%132M | 16.26%143M | -11.80%142M | 8.70%125M | -24.84%115M | 10.00%143M | 3.36%123M |
Current changes in cash | 40.00%-6M | -200.00%-1M | ---- | ---- | -137.04%-10M | 103.03%1M | -66.67%16M | 152.94%18M | -71.43%-24M | 125.00%27M |
Effect of exchange rate changes | 400.00%3M | ---1M | 125.00%2M | -66.67%2M | 85.71%-1M | --0 | 150.00%1M | -100.00%-8M | 700.00%6M | -600.00%-7M |
End cash Position | 12.88%149M | 6.29%152M | 1.60%127M | 1.60%127M | -7.69%132M | 16.26%143M | -11.80%142M | 8.70%125M | 8.70%125M | 10.00%143M |
Free cash flow | -41.82%96M | 41.79%95M | 23.19%409M | 101.82%111M | 60.19%165M | 1.52%67M | -38.89%66M | 56.60%332M | -9.84%55M | 80.70%103M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |